Clari Vest Asset Management LLC Ardelyx, Inc. Transaction History

Clari Vest Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$3.29 - $6.64 $521,132 - $1.05 Million	158,399 New	158,399 $982,000
Q1 2019 May 13, 2019	BUY	$1.88 - $3.35 $69,372 - $123,615	36,900 Added 48.24%	113,400 $318,000
Q4 2018 Feb 05, 2019	SELL	$1.66 - $4.16 $12,948 - $32,448	-7,800 Reduced 9.25%	76,500 $137,000
Q3 2018 Nov 07, 2018	BUY	$3.75 - $4.65 $54,750 - $67,890	14,600 Added 20.95%	84,300 $367,000
Q2 2018 Aug 10, 2018	BUY	$3.7 - $5.8 $2,220 - $3,480	600 Added 0.87%	69,700 $258,000
Q1 2018 May 08, 2018	BUY	$5.05 - $7.9 $8,080 - $12,640	1,600 Added 2.37%	69,100 $349,000
Q3 2017 Nov 07, 2017	BUY	$4.35 - $5.7 $2,610 - $3,420	600 Added 0.9%	67,500 $378,000
Q2 2017 Nov 20, 2017	BUY	N/A	66,900	66,900 $341,000

219

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $815M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.